Jane Street Group, LLC Seelos Therapeutics, Inc. Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.16 - $1.64 $6,952 - $71,259	43,451 New	43,451 $7,000
Q1 2023 May 15, 2023	BUY	$0.59 - $1.04 $10,786 - $19,014	18,283 New	18,283 $12,000
Q2 2022 Aug 16, 2022	BUY	$0.51 - $0.93 $1,933 - $3,525	3,791 Added 17.92%	24,951 $17,000
Q1 2022 May 17, 2022	SELL	$0.84 - $1.71 $26,136 - $53,206	-31,115 Reduced 59.52%	21,160 $18,000
Q4 2021 Feb 15, 2022	SELL	$1.59 - $2.38 $57,890 - $86,653	-36,409 Reduced 41.05%	52,275 $85,000
Q2 2021 Aug 16, 2021	SELL	$2.64 - $6.32 $1.07 Million - $2.56 Million	-405,451 Reduced 82.05%	88,684 $234,000
Q1 2021 May 18, 2021	BUY	$1.35 - $4.99 $647,113 - $2.39 Million	479,343 Added 3240.56%	494,135 $2.47 Million
Q4 2020 Feb 17, 2021	BUY	$0.74 - $2.01 $10,946 - $29,731	14,792 New	14,792 $23,000
Q3 2020 Nov 17, 2020	SELL	$0.6 - $1.25 $7,066 - $14,721	-11,777 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.42 - $1.51 $4,946 - $17,783	11,777 New	11,777 $12,000
Q2 2019 Aug 15, 2019	SELL	$2.11 - $3.3 $105,711 - $165,330	-50,100 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$1.45 - $8.1 $72,645 - $405,810	50,100 New	50,100 $168,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.